Evidence map›Paper›PMID 39441873›Full record

ArticlePloS one2024

Investigating the effects of a daily multidisciplinary intensive outpatient rehabilitation program on innovative biomarkers in people with Parkinson's disease: Study protocol for a phase III randomized controlled clinical trial.

Francesca Lea Saibene, Cristina Agliardi, Anna Salvatore, Pietro Arcuri, Anna Castagna, Silvia Gobbo, Federico Merlo, Thomas Bowman, Denise Anastasi, Chiara Pagliari and 12 more

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05452655 (Effects of Intensive Multidisciplinary Rehabilitation and Identification of New Biomarkers in Response to an Integrated Motor-Cognitive and Aerobic Exercises Approaches in People With Parkinson's Disease), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05452655 naunknown statusnot on this map

Effects of Intensive Multidisciplinary Rehabilitation and Identification of New Biomarkers in Response to an Integrated Motor-Cognitive and Aerobic Exercises Approaches in People With Parkinson's Disease

TypeinterventionalSponsorFondazione Don Carlo Gnocchi ETSRan2020 to 2023Enrolled72ConditionsParkinson Disease, Biomarkers, Rehabilitation Outcome, Gait Disorders, NeurologicArmsMultidisciplinary Intensive Rehabilitation, Muscle-stretching and active mobilization exercises
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Intensive multidisciplinary rehabilitation modulates serumFrontiers in cellular neuroscience · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Francesca Lea SaibeneIRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy.
Cristina AgliardiIRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy.
Anna SalvatoreIRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy.ORCID 0000-0002-7655-3555
Pietro ArcuriIRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy.
Anna CastagnaIRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy.
Silvia GobboIRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy.
Federico MerloIRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy.
Thomas BowmanIRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy.
Denise AnastasiDepartment of Biomedical Sciences, University of Sassari, Sassari, Italy.
Chiara PagliariIRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy.ORCID 0000-0002-2801-9550
Elisabetta FarinaIRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy.
Margherita AlberoniIRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy.
Elena CalabreseIRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy.
Francesca La RosaIRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy.
Chiara ArientiIRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy.
Marina SaresellaIRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy.
Franca Rosa GueriniIRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy.
Davide CattaneoIRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy.
Francesca BaglioIRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy.
Mario ClericiIRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy.
Jorge NavarroIRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan, Italy.
Mario MeloniNeurology Unit, Azienda Ospedaliero-Universitaria, Cagliari, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo date, there has been no medication that has prevented the progression of Parkinson's disease (PD). Many benefits of intensive and multidisciplinary rehabilitation program for PD are supported by clinical, epidemiological, and experimental data. The main question is whether high-intensity motor and cognitive exercises have an effect on the disease's biological mechanisms.

objectiveThis study protocol is a Randomized Controlled Trial (RCT) designed to determine the efficacy of an experimental, intensive, and multidisciplinary treatment in comparison to a home-based self-treatment in improving biomolecular and functional parameters in PD.

methodsA total of 72 participants will be randomly allocated to two different groups, experimental (n = 36) and control group (n = 36). The rehabilitation program will last 6 consecutive weeks and will involve the execution of a total of 30 sessions, one for each day of the week from Monday to Friday. Participants allocated to the control group will carry out a home-based self-treatment program that includes muscle-stretching and active mobilization exercises for 40'/day for 6 consecutive weeks. The primary outcome measure is the effects of both treatments on a new set of molecular biomarkers such as oligomeric alpha-synuclein and neurotrophic factors measured in peripheral neural derived extracellular vesicles (NDEVs). Secondary outcomes will include changes of motor and non-motor symptoms, balance and gait performance and cognitive functioning. This RCT has been registered as "Intensive Multidisciplinary Rehabilitation and Biomarkers in Parkinson's Disease" on 30 May, 2022 to ClinicalTrials.gov with the Study ID number: NCT05452655. DISCUSSION: This rehabilitation program is believed to be crucial in modifying biomolecular and functional parameters in people with PD. We expect that this study will provide additional evidence to understand the impact of an aerobic and intensive rehabilitation program on brain plasticity in patients with PD.

Indexed as

BiomarkersParkinson DiseaseAgedalpha-SynucleinClinical Trials, Phase III as TopicExercise TherapyFemaleHumansMaleMiddle AgedOutpatientsRandomized Controlled Trials as Topicalpha-SynucleinBiomarkers

Identifiers

PMID39441873
PMCPMC11498734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.